2 services found
Champions Oncology, Inc. Services
-
Research Services & Partnering - Translational Research - Immuno-Oncology Platforms
Immuno-Oncology is a scientific field that involves developing therapeutics that take advantage of the body`s immune system to fight cancer. Champions Oncology has developed innovative platforms that give Immuno-oncology researchers the tools they need to test their therapeutic drug`s mechanism of action. The Autologous TIL platform is an ex vivo 3D co-culture platform developed to interrogate the responses of your Immuno-Oncology drugs with a tumor-specific microenvironment using PDX-O (patient-derived xenograft organoids) collected with matched, autologous TIL samples. The Autologous AML platform is an ex vivo co-culture platform developed and optimized to interrogate the responses of your immuno-oncology drugs in only 4 days using primary patient-matched specimens.
-
Autologous Tumor Infiltrating Lymphocyte (TIL) Platform
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D co-culture platform developed and optimized to interrogate the responses of your Immuno-Oncology drugs with a tumor-specific ...
-
Autologous AML Platform
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture assay developed and optimized to interrogate the responses of your immuno-oncology drugs in only 4 days using primary patient ...